Abstract
Antihypertensive agents exert different effects on insulin sensitivity, lipids and haemostasis. However, most studies assessing these effects were small and short-term yielding conflicting results. Moreover, it has not been established whether the impact of antihypertensive drugs on insulin sensitivity, lipids, thrombosis and fibrinolysis adds to or attenuates vascular risk reduction. On the other hand, new onset type 2 diabetes mellitus (T2DM) appears to be more frequent in patients treated with β-blockers and diuretics, whereas angiotensin converting enzyme inhibitors and angiotensin receptor blockers might reduce the risk for T2DM and calcium channel blockers have a neutral effect. Therefore, the risk of developing T2DM should be considered when selecting an antihypertensive agent. This review discusses the differential effects of antihypertensive drugs on insulin sensitivity, lipids and haemostasis and considers their association with vascular risk.
Keywords: Thrombosis, fibrinolysis, lipids, insulin sensitivity, diabetes mellitus, diuretics, β-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, Antihypertensive Agents, Haemostasis, blockers, hypertension, prothrombotic factors, visceral obesity, dyslipidaemia, hypercoagulability, Framingham cohort, glucose intolerant, Heart Outcomes Prevention Evaluation, Left Ventricular Dysfunction, Felodipine Event Reduction, HCTZ monotherapy, trandolapril, thiazide diuretics, chlorthalidone, amlodipine, ACE inhibition, amiloride, pindolol, hypokalaemia, Celiprolol, Multiple Risk Factor Intervention Trial, lipoprotein cholesterol, intrinsic sympathomimetic activity, Prazosin, plasminogen activator inhibitor, Atenolol, fosinopril, cilazapril, quinapril, Microalbuminu-ria, candesartan, losartan, doxazosin, indapamide, Lisinopril, Perindopril
Current Vascular Pharmacology
Title: The Effect of Antihypertensive Agents on Insulin Sensitivity, Lipids and Haemostasis
Volume: 8 Issue: 6
Author(s): Asterios Karagiannis, Konstantinos Tziomalos, Panagiotis Anagnostis, Thomas D. Gossios, Matilda Florentin, Vasilios G. Athyros and Dimitri P. Mikhailidis
Affiliation:
Keywords: Thrombosis, fibrinolysis, lipids, insulin sensitivity, diabetes mellitus, diuretics, β-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, Antihypertensive Agents, Haemostasis, blockers, hypertension, prothrombotic factors, visceral obesity, dyslipidaemia, hypercoagulability, Framingham cohort, glucose intolerant, Heart Outcomes Prevention Evaluation, Left Ventricular Dysfunction, Felodipine Event Reduction, HCTZ monotherapy, trandolapril, thiazide diuretics, chlorthalidone, amlodipine, ACE inhibition, amiloride, pindolol, hypokalaemia, Celiprolol, Multiple Risk Factor Intervention Trial, lipoprotein cholesterol, intrinsic sympathomimetic activity, Prazosin, plasminogen activator inhibitor, Atenolol, fosinopril, cilazapril, quinapril, Microalbuminu-ria, candesartan, losartan, doxazosin, indapamide, Lisinopril, Perindopril
Abstract: Antihypertensive agents exert different effects on insulin sensitivity, lipids and haemostasis. However, most studies assessing these effects were small and short-term yielding conflicting results. Moreover, it has not been established whether the impact of antihypertensive drugs on insulin sensitivity, lipids, thrombosis and fibrinolysis adds to or attenuates vascular risk reduction. On the other hand, new onset type 2 diabetes mellitus (T2DM) appears to be more frequent in patients treated with β-blockers and diuretics, whereas angiotensin converting enzyme inhibitors and angiotensin receptor blockers might reduce the risk for T2DM and calcium channel blockers have a neutral effect. Therefore, the risk of developing T2DM should be considered when selecting an antihypertensive agent. This review discusses the differential effects of antihypertensive drugs on insulin sensitivity, lipids and haemostasis and considers their association with vascular risk.
Export Options
About this article
Cite this article as:
Karagiannis Asterios, Tziomalos Konstantinos, Anagnostis Panagiotis, D. Gossios Thomas, Florentin Matilda, G. Athyros Vasilios and P. Mikhailidis Dimitri, The Effect of Antihypertensive Agents on Insulin Sensitivity, Lipids and Haemostasis, Current Vascular Pharmacology 2010; 8 (6) . https://dx.doi.org/10.2174/157016110793563906
DOI https://dx.doi.org/10.2174/157016110793563906 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Ischemic Cardiovascular Diseases: Mechanisms, Diagnosis and Therapy
Ischemic cardiovascular disease includes myocardial infarction, coronary atherosclerotic heart disease, angina pectoris, etc., constitute the leading cause of patient mortality by preventing tissues from getting sufficient oxygen and nutrients. Ischemic heart disease, as a clinical condition, is characterized by myocardial ischemia, causing an imbalance between myocardial blood supply and demand, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Adipose Tissue as a Source of Vasoactive Factors
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Combination of Captopril with Gliclazide Decreases Vascular and Renal Complications and Improves Glycemic Control in Rats with Streptozotocin- Induced Diabetes Mellitus
Endocrine, Metabolic & Immune Disorders - Drug Targets Functional Profiles of Human Umbilical Cord-Derived Adult Mesenchymal Stem Cells in Obese/Diabetic Versus Healthy Women
Current Diabetes Reviews Treatment Possibilities for Psychosis in Parkinson's Disease with An Emphasis on the Newly Approved Drug: Pimavanserin
CNS & Neurological Disorders - Drug Targets Glucocorticoids Pharmacology: Past, Present and Future
Current Pharmaceutical Design History, Prevalence and Assessment of Limited Joint Mobility, from Stiff Hand Syndrome to Diabetic Foot Ulcer Prevention: A Narrative Review of the Literature
Current Diabetes Reviews Relevance of Dyslipidaemia and its Consequences in Periodontal Patients with Co-Existing Cardiovascular Disease and Diabetes Mellitus: Therapeutic Targets
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Neuroprotective Effects of Lithium in Patients with Bipolar Disorder
Current Psychopharmacology Anti-VEGF Anticancer Drugs: Mind the Hypertension
Recent Advances in Cardiovascular Drug Discovery (Discontinued) “Something is Wrong in the Ras Kingdom” - Evidence for the Involvement of p21Ras/MAP Kinase in Autoimmune Diseases
Current Rheumatology Reviews Central Nervous System Depressants and Risk of Hospitalization due to Community-Acquired Pneumonia in very Old Patients
Current Drug Safety The Lung Disease of Rheumatoid Arthritis
Current Respiratory Medicine Reviews Advances in the Generation of Functional β-cells from Induced Pluripotent Stem Cells As a Cure for Diabetes Mellitus
Current Drug Targets A Novel Nanoformulation of Ellagic Acid is Promising in Restoring Oxidative Homeostasis in Rat Brains with Alzheimer’s Disease
Current Drug Metabolism Polyoxometalates in Biomedicine: Update and Overview
Current Medicinal Chemistry The Relationship Between Diabetes Mellitus, Geriatric Syndromes, Physical Function, and Gait: A Review of the Literature
Current Diabetes Reviews An Overview of Phytochemical and Pharmacological Profile of <i>Morus alba</i> Linn
Current Bioactive Compounds Recombinant Human Insulin-Like Growth Factor-1: A New Cardiovascular Disease Treatment Option?
Cardiovascular & Hematological Agents in Medicinal Chemistry Vascular Protective Effects of Diabetes Medications that Mimic or Increase Glucagon-Like Peptide-1 Activity
Recent Patents on Cardiovascular Drug Discovery Glycation and Antioxidants: Hand in the Glove of Antiglycation and Natural Antioxidants
Current Protein & Peptide Science